Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover
In This Article:
IGM stock crashed Tuesday after the biotech company scrapped development of a cancer drug and announced three of its executives stepped down.
Oops, something went wrong
IGM stock crashed Tuesday after the biotech company scrapped development of a cancer drug and announced three of its executives stepped down.